Last updated 2026-06-18
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Enavate Sciences' investment focus?
- Enavate Sciences supports therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient needs.
- Which sectors does Enavate Sciences primarily invest in?
- Enavate Sciences has a primary focus on the Health Tech & Life Sciences sector.
- Has Enavate Sciences made any recent investments?
- Yes, Enavate Sciences participated in a B Round for Upstream Bio in June 2023.
- What is a notable portfolio company for Enavate Sciences?
- Upstream Bio, a company developing a monoclonal antibody drug for asthma patients, is a notable portfolio company for Enavate Sciences.
- What was the size of the funding round for Upstream Bio that Enavate Sciences participated in?
- Enavate Sciences participated in a B Round for Upstream Bio, which raised $400M.
- What stage investments does Enavate Sciences typically make?
- Enavate Sciences has participated in B Round investments, such as their investment in Upstream Bio.
- What is Enavate Sciences' typical investment range?
- Enavate Sciences' investment range is $200M - $200M.